340 related articles for article (PubMed ID: 35265969)
1. The role of astrocytes in prion-like mechanisms of neurodegeneration.
Smethurst P; Franklin H; Clarke BE; Sidle K; Patani R
Brain; 2022 Mar; 145(1):17-26. PubMed ID: 35265969
[TBL] [Abstract][Full Text] [Related]
2. Generalization of the prion hypothesis to other neurodegenerative diseases: an imperfect fit.
Guest WC; Silverman JM; Pokrishevsky E; O'Neill MA; Grad LI; Cashman NR
J Toxicol Environ Health A; 2011; 74(22-24):1433-59. PubMed ID: 22043906
[TBL] [Abstract][Full Text] [Related]
3. Invited Review: The role of prion-like mechanisms in neurodegenerative diseases.
Jaunmuktane Z; Brandner S
Neuropathol Appl Neurobiol; 2020 Oct; 46(6):522-545. PubMed ID: 31868945
[TBL] [Abstract][Full Text] [Related]
4. [The Propagation Hypothesis of Prion-like Protein Agregates in Neurodegenerative Diseases].
Nonaka T
Brain Nerve; 2019 Nov; 71(11):1209-1214. PubMed ID: 31722306
[TBL] [Abstract][Full Text] [Related]
5. The cell biology of prion-like spread of protein aggregates: mechanisms and implication in neurodegeneration.
Costanzo M; Zurzolo C
Biochem J; 2013 May; 452(1):1-17. PubMed ID: 23614720
[TBL] [Abstract][Full Text] [Related]
6. Deciphering the prion-like behavior of pathogenic protein aggregates in neurodegenerative diseases.
Yoshida S; Hasegawa T
Neurochem Int; 2022 May; 155():105307. PubMed ID: 35181393
[TBL] [Abstract][Full Text] [Related]
7. [Can prion-like propagation occur in neurodegenerative diseases?: in view of transmissible systemic amyloidosis].
Yoshida K; Higuchi K; Ikeda S
Brain Nerve; 2012 Jun; 64(6):665-74. PubMed ID: 22647474
[TBL] [Abstract][Full Text] [Related]
8. Propagation of the prion phenomenon: beyond the seeding principle.
Münch C; Bertolotti A
J Mol Biol; 2012 Aug; 421(4-5):491-8. PubMed ID: 22245492
[TBL] [Abstract][Full Text] [Related]
9. Synthetic prions and other human neurodegenerative proteinopathies.
Le NT; Narkiewicz J; Aulić S; Salzano G; Tran HT; Scaini D; Moda F; Giachin G; Legname G
Virus Res; 2015 Sep; 207():25-37. PubMed ID: 25449570
[TBL] [Abstract][Full Text] [Related]
10. The spread of prion-like proteins by lysosomes and tunneling nanotubes: Implications for neurodegenerative diseases.
Victoria GS; Zurzolo C
J Cell Biol; 2017 Sep; 216(9):2633-2644. PubMed ID: 28724527
[TBL] [Abstract][Full Text] [Related]
11. The propagation of prion-like protein inclusions in neurodegenerative diseases.
Goedert M; Clavaguera F; Tolnay M
Trends Neurosci; 2010 Jul; 33(7):317-25. PubMed ID: 20493564
[TBL] [Abstract][Full Text] [Related]
12. POSCAbilities: The Application of the Prion Organotypic Slice Culture Assay to Neurodegenerative Disease Research.
Pineau H; Sim V
Biomolecules; 2020 Jul; 10(7):. PubMed ID: 32698402
[TBL] [Abstract][Full Text] [Related]
13. Mechanisms of prion-induced toxicity.
Mercer RCC; Harris DA
Cell Tissue Res; 2023 Apr; 392(1):81-96. PubMed ID: 36070155
[TBL] [Abstract][Full Text] [Related]
14. Disease-associated protein seeding suggests a dissociation between misfolded protein accumulation and neurodegeneration in prion disease.
Alibhai J; Diack A; Manson J
Prion; 2017 Nov; 11(6):381-387. PubMed ID: 29023184
[TBL] [Abstract][Full Text] [Related]
15. RNA-seq and network analysis reveal unique glial gene expression signatures during prion infection.
Carroll JA; Race B; Williams K; Striebel J; Chesebro B
Mol Brain; 2020 May; 13(1):71. PubMed ID: 32381108
[TBL] [Abstract][Full Text] [Related]
16. Decoding the Cellular Trafficking of Prion-like Proteins in Neurodegenerative Diseases.
Hu C; Yan Y; Jin Y; Yang J; Xi Y; Zhong Z
Neurosci Bull; 2024 Feb; 40(2):241-254. PubMed ID: 37755677
[TBL] [Abstract][Full Text] [Related]
17. Sustained translational repression by eIF2α-P mediates prion neurodegeneration.
Moreno JA; Radford H; Peretti D; Steinert JR; Verity N; Martin MG; Halliday M; Morgan J; Dinsdale D; Ortori CA; Barrett DA; Tsaytler P; Bertolotti A; Willis AE; Bushell M; Mallucci GR
Nature; 2012 May; 485(7399):507-11. PubMed ID: 22622579
[TBL] [Abstract][Full Text] [Related]
18. Neuroglial patterns are shared by cerebella from prion and prion-like disorder affected patients.
Garcés M; Guijarro MI; Vargas A; Badiola JJ; Monzón M
Mech Ageing Dev; 2019 Dec; 184():111176. PubMed ID: 31689427
[TBL] [Abstract][Full Text] [Related]
19. From Seeds to Fibrils and Back: Fragmentation as an Overlooked Step in the Propagation of Prions and Prion-Like Proteins.
Marrero-Winkens C; Sankaran C; Schätzl HM
Biomolecules; 2020 Sep; 10(9):. PubMed ID: 32927676
[TBL] [Abstract][Full Text] [Related]
20. The prion-like nature of amyotrophic lateral sclerosis.
McAlary L; Yerbury JJ; Cashman NR
Prog Mol Biol Transl Sci; 2020; 175():261-296. PubMed ID: 32958236
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
